ECSP10010347A - (r)-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida cristalina - Google Patents

(r)-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida cristalina

Info

Publication number
ECSP10010347A
ECSP10010347A EC2010010347A ECSP10010347A ECSP10010347A EC SP10010347 A ECSP10010347 A EC SP10010347A EC 2010010347 A EC2010010347 A EC 2010010347A EC SP10010347 A ECSP10010347 A EC SP10010347A EC SP10010347 A ECSP10010347 A EC SP10010347A
Authority
EC
Ecuador
Prior art keywords
propionamide
crystalline
phenyl
cyclopropansulphonyl
tetrahydropiran
Prior art date
Application number
EC2010010347A
Other languages
English (en)
Inventor
Jeanette Tower Dunlap
Gregory Alan Stephenson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40451065&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP10010347(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ECSP10010347A publication Critical patent/ECSP10010347A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a R-2-(4-ciclopropansulfonil-fenil)-N-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida cristalina, y a métodos para su preparación y uso.
EC2010010347A 2008-01-15 2010-07-15 (r)-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida cristalina ECSP10010347A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2113308P 2008-01-15 2008-01-15

Publications (1)

Publication Number Publication Date
ECSP10010347A true ECSP10010347A (es) 2010-09-30

Family

ID=40451065

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2010010347A ECSP10010347A (es) 2008-01-15 2010-07-15 (r)-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida cristalina

Country Status (22)

Country Link
US (1) US20090181981A1 (es)
EP (1) EP2265271A1 (es)
JP (1) JP2011509934A (es)
KR (1) KR20100092061A (es)
CN (1) CN101909629A (es)
AR (1) AR070107A1 (es)
AU (1) AU2009205606A1 (es)
BR (1) BRPI0907165A2 (es)
CA (1) CA2712245A1 (es)
CL (1) CL2009000004A1 (es)
CO (1) CO6280489A2 (es)
DO (1) DOP2010000216A (es)
EA (1) EA201070853A1 (es)
EC (1) ECSP10010347A (es)
IL (1) IL206102A0 (es)
MA (1) MA31985B1 (es)
MX (1) MX2010007784A (es)
PE (1) PE20091313A1 (es)
TN (1) TN2010000299A1 (es)
TW (1) TW200934772A (es)
WO (1) WO2009091634A1 (es)
ZA (1) ZA201003909B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008290329B2 (en) 2007-08-22 2011-12-22 Astrazeneca Ab Cyclopropyl amide derivatives
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
BR112012020780A2 (pt) * 2010-02-18 2016-05-03 Astrazeneca Ab forma sólida, composição farmacêutica, e, uso de uma forma sólida.
NZ602110A (en) 2010-02-18 2014-09-26 Astrazeneca Ab Processes for making cyclopropyl amide derivatives and intermediates associated therewith
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
KR101220371B1 (ko) 2010-09-17 2013-01-09 현대자동차주식회사 베인펌프
US20140020618A1 (en) * 2011-02-08 2014-01-23 Japan Agency For Marine-Earth Science And Technology Method for producing calcite single crystal
JP2013014534A (ja) * 2011-07-04 2013-01-24 Daicel Corp ベンゾイルギ酸化合物、及びその製造方法
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4046768A (en) * 1976-06-17 1977-09-06 Velsicol Chemical Corporation 1-Thiazolyl-5-pyridylcarbonyloxyimidazolidinones
US6320050B1 (en) * 1999-03-29 2001-11-20 Hoffmann-La Roche Inc. Heteroaromatic glucokinase activators
US6610846B1 (en) * 1999-03-29 2003-08-26 Hoffman-La Roche Inc. Heteroaromatic glucokinase activators
US6353111B1 (en) * 1999-12-15 2002-03-05 Hoffmann-La Roche Inc. Trans olefinic glucokinase activators
AU7049401A (en) * 2000-05-03 2001-11-12 Hoffmann La Roche Alkynyl phenyl heteroaromatic glucokinase activators
EP1282611B1 (en) * 2000-05-08 2004-10-20 F. Hoffmann-La Roche Ag Substituted phenylacetamides and their use as glucokinase activators
US6489485B2 (en) * 2000-05-08 2002-12-03 Hoffmann-La Roche Inc. Para-amine substituted phenylamide glucokinase activators
MXPA03000365A (es) * 2000-07-20 2003-05-27 Hoffmann La Roche Bencenacetamida substituida con alfa-acilo y alfa-heteroatomo como activadores de la glucocinasa.
US6369232B1 (en) * 2000-08-15 2002-04-09 Hoffmann-La Roche Inc. Tetrazolyl-phenyl acetamide glucokinase activators
JP4109111B2 (ja) * 2000-12-06 2008-07-02 エフ．ホフマン−ラ ロシュ アーゲー 縮合複素環式芳香族グルコキナーゼアクチベーター
US6433188B1 (en) * 2000-12-06 2002-08-13 Wendy Lea Corbett Fused heteroaromatic glucokinase activators
US6482951B2 (en) * 2000-12-13 2002-11-19 Hoffmann-La Roche Inc. Isoindolin-1-one glucokinase activators
US6911545B2 (en) * 2001-12-19 2005-06-28 Hoffman-La Roche Inc. Crystals of glucokinase and methods of growing them
EP1594863A1 (en) * 2003-02-11 2005-11-16 Prosidion Limited Tri(cyclo) substituted amide glucokinase activator compounds
PL378117A1 (pl) * 2003-02-11 2006-03-06 Prosidion Limited Tricyklopodstawione związki amidowe
KR20060134179A (ko) * 2004-04-21 2006-12-27 프로시디온 리미티드 트리(사이클로) 치환된 아미드 화합물
MX2007001650A (es) * 2004-08-12 2007-07-13 Prosidion Ltd Fenilacetamidas substituidas y su uso como activadores de glucocinasa.
GB0418058D0 (en) * 2004-08-12 2004-09-15 Prosidion Ltd Fluorination process
GB0418046D0 (en) * 2004-08-12 2004-09-15 Prosidion Ltd Eantioselective process
US20080293741A1 (en) * 2005-11-03 2008-11-27 Matthew Colin Thor Fyfe Tricyclo Substituted Amides as Glucokinase Modulators
CA2628486A1 (en) * 2005-11-03 2007-05-10 Prosidion Ltd. Tricyclo substituted amides
CA2626475A1 (en) * 2005-11-03 2007-05-10 Prosidion Limited Tricyclo substituted amides

Also Published As

Publication number Publication date
CL2009000004A1 (es) 2010-02-19
WO2009091634A1 (en) 2009-07-23
US20090181981A1 (en) 2009-07-16
MX2010007784A (es) 2010-08-09
ZA201003909B (en) 2011-11-30
DOP2010000216A (es) 2010-10-15
AU2009205606A1 (en) 2009-07-23
EA201070853A1 (ru) 2010-12-30
PE20091313A1 (es) 2009-09-03
IL206102A0 (en) 2010-11-30
BRPI0907165A2 (pt) 2015-07-14
TW200934772A (en) 2009-08-16
TN2010000299A1 (en) 2011-11-11
CA2712245A1 (en) 2009-07-23
JP2011509934A (ja) 2011-03-31
CN101909629A (zh) 2010-12-08
EP2265271A1 (en) 2010-12-29
MA31985B1 (fr) 2011-01-03
CO6280489A2 (es) 2011-05-20
KR20100092061A (ko) 2010-08-19
AR070107A1 (es) 2010-03-17

Similar Documents

Publication Publication Date Title
DOP2010000216A (es) (r)-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida cristalina
CR11776A (es) Inhibidores de bace
ECSP12011581A (es) Inhibidores de bace
MX2022010755A (es) Inhibidores de quinasa y usos de los mismos.
UY33124A (es) Agentes y epítopos enlazados a wise
AU2013291345B2 (en) Composition for controlling plant disease and application therefor
UA107791C2 (en) Pesticidal compositions
DK3106463T6 (da) Pyrazolo[1,5-]pyrimidinforbindelse som trk-kinasehæmmer
DK2516433T3 (da) Substituerede n-(1h-indazol-4-yl)imidazo[1,2-a]pyridin-3-carboxamidforbindelser som cfms-inhibitorer
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
BR112013004025A2 (pt) amarra para uso hortícola
BRPI0918472A2 (pt) composto 2,4-diaminopirimidina
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
IT1394472B1 (it) Tavolo per riunioni.
BRPI0823256A2 (pt) Uso de sacarose como substrato para produção fermentativa de 1,2-propanodiol
EA201101148A1 (ru) Новые гербициды
EA201101146A1 (ru) Новые гербициды
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
BRPI0913267A2 (pt) uso do ácido succínico
RS54488B1 (en) NALOXOL-POLYETHYLENE GLYCOL CRYSTAL CONJUGATE
EA201101097A1 (ru) Новые микробиоциды
ECSP088740A (es) Derivados de tetrahidronaftalina, procedimientos para prepararlos y su uso como antiinflamatorios
WO2009127718A3 (en) Novel microbiocides
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI1012047A2 (pt) compostos dímeros contendo oxazolidinona, composições e métodos para fazer e uso